Published in Am J Med on September 01, 1995
The misconduct of redundant publication. Ann Rheum Dis (1996) 1.94
Role of endothelin-1 in lung disease. Respir Res (2001) 1.36
Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol (2004) 1.16
Recent achievements in the management of Raynaud's phenomenon. Vasc Health Risk Manag (2010) 1.02
Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol (2013) 0.95
NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity. Arthritis Res Ther (2006) 0.87
Notice of redundant publication. Ann Rheum Dis (1996) 0.86
Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study. Clin Rheumatol (2013) 0.86
A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clin Rheumatol (2005) 0.85
Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis. Rheumatol Int (2008) 0.85
T cell repertoire in patients with stable scleroderma. Clin Exp Immunol (2005) 0.82
Urotensin-II in systemic sclerosis: a new peptide in pathogenesis. Clin Rheumatol (2011) 0.81
Application of biomarkers to clinical trials in systemic sclerosis. Curr Rheumatol Rep (2012) 0.81
No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis. Clin Rheumatol (2009) 0.80
Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients. Clin Rheumatol (2009) 0.79
Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice. Arthritis Res Ther (2016) 0.75
Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis. J Clin Rheumatol Musculoskelet Med (2010) 0.75
From the editor. Am J Med (1996) 0.75
Nailfold videocapillaroscopy results in patients with rheumatoid arthritis. Clin Rheumatol (2017) 0.75
[Laboratory diagnostics for systemic sclerosis]. Z Rheumatol (2007) 0.75
Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients. Rheumatol Int (2017) 0.75
AGO1 defines a novel locus of Arabidopsis controlling leaf development. EMBO J (1998) 5.62
Superroot, a recessive mutation in Arabidopsis, confers auxin overproduction. Plant Cell (1995) 5.55
AGO1, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals. Proc Natl Acad Sci U S A (2000) 5.03
Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant (2007) 4.50
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension (1994) 3.79
Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant (2010) 3.48
Sur2 mutations of Arabidopsis thaliana define a new locus involved in the control of auxin homeostasis. Plant J (1998) 2.81
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
The SUR2 gene of Arabidopsis thaliana encodes the cytochrome P450 CYP83B1, a modulator of auxin homeostasis. Proc Natl Acad Sci U S A (2000) 2.71
Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett (1993) 2.65
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis (2010) 2.40
ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38
Procuste1 mutants identify two distinct genetic pathways controlling hypocotyl cell elongation, respectively in dark- and light-grown Arabidopsis seedlings. Development (1996) 2.34
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol (1996) 2.11
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol (2012) 2.02
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol (2000) 1.99
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
FACKEL is a sterol C-14 reductase required for organized cell division and expansion in Arabidopsis embryogenesis. Genes Dev (2000) 1.92
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem (1998) 1.83
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis (2004) 1.80
Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol (2000) 1.76
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol (1995) 1.65
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64
Higher activity of an aldehyde oxidase in the auxin-overproducing superroot1 mutant of Arabidopsis thaliana. Plant Physiol (1998) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Leishmania in SLE mimicking an exacerbation. Clin Exp Rheumatol (2006) 1.54
Mutation in the Arabidopsis PASTICCINO1 gene, which encodes a new FK506-binding protein-like protein, has a dramatic effect on plant development. Mol Cell Biol (1998) 1.54
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol (1997) 1.54
Musculoskeletal and adipose tissue hydatidosis based on the iatrogenic spreading of cystic fluid during surgery: report of a case. Surg Today (2000) 1.52
Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol (1998) 1.51
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum (2005) 1.49
Botulinum neurotoxins are zinc proteins. J Biol Chem (1992) 1.48
FKBPs: at the crossroads of folding and transduction. Trends Plant Sci (2001) 1.43
Cardiac involvement in Behçet's disease. Cardiology (1998) 1.42
Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ (2004) 1.42
Do Behçet's syndrome patients with acne and arthritis comprise a true subset? Comment on the article by Hatemi et al. Arthritis Rheum (2009) 1.40
MRI in Smith-Lemli-Opitz syndrome type I. Childs Nerv Syst (1997) 1.39
The PASTICCINO genes of Arabidopsis thaliana are involved in the control of cell division and differentiation. Development (1998) 1.36
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia (2007) 1.36
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension. Ann Rheum Dis (1995) 1.34
Three high-lysine mutations control the level of ATP-binding HSP70-like proteins in the maize endosperm. Plant Cell (1991) 1.29
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect Immun (1994) 1.24
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1996) 1.24
Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol (2010) 1.21
Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis (1999) 1.19
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med (1996) 1.18
A randomised control study comparing the Infant Flow Driver with nasal continuous positive airway pressure in preterm infants. Arch Dis Child Fetal Neonatal Ed (2001) 1.17
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol (2004) 1.16
Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int (2000) 1.14
Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension (1999) 1.12
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci (2005) 1.11
Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin Exp Immunol (2000) 1.11
Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation (1999) 1.11
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum (2009) 1.10
Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol (1985) 1.10
Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum (2000) 1.10
Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol (1991) 1.09
Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab (1995) 1.09
Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol (1997) 1.09
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients. Cephalalgia (2008) 1.09
Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis (2006) 1.08
T(14;18) translocation in chronic hepatitis C virus infection. Hepatology (2000) 1.08
Clinical outcome of closed isolated subtalar dislocations. Arch Orthop Trauma Surg (2007) 1.08
Mapping of Chlamydia trachomatis proteins by immobiline-polyacrylamide two-dimensional electrophoresis: spot identification by N-terminal sequencing and immunoblotting. Electrophoresis (1996) 1.07
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemost (1990) 1.07
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun (1994) 1.06
Conformations and biological activities of amyloid beta peptide 25-35. Curr Protein Pept Sci (2010) 1.05
Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis (2005) 1.04
Bilateral simultaneous cerebellar infarction in the medial branches of the posterior inferior cerebellar artery territories. Ital J Neurol Sci (1996) 1.04
Sarcomatoid carcinoma of the kidney. J Urol (1987) 1.04
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol (2003) 1.04
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis (2001) 1.04
HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol (2008) 1.03
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. Am J Pathol (1998) 1.02
Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci (2004) 1.02
Non-Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA (1994) 1.01
Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. J Clin Oncol (1999) 1.01
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis. Arch Virol (1990) 1.01
Purification and characterization of glutathione-dependent dehydroascorbate reductase from rat liver. Biochem J (1994) 1.00
Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol (2000) 1.00
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. Rheumatology (Oxford) (2008) 1.00
Magnetic resonance colonography versus conventional colonoscopy for the detection of colonic endoluminal lesions. Gastroenterology (2000) 0.99
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis (2002) 0.99